peginterferon alfa-2b and ribavirin plus pitavastatin for chronic hepatitis type C : A pilot study

Trial Profile

peginterferon alfa-2b and ribavirin plus pitavastatin for chronic hepatitis type C : A pilot study

Completed
Phase of Trial: Phase I/II

Latest Information Update: 28 Jun 2012

At a glance

  • Drugs Peginterferon alfa-2b (Primary) ; Pitavastatin (Primary) ; Ribavirin (Primary)
  • Indications Hepatitis C
  • Focus Therapeutic Use
  • Most Recent Events

    • 28 Jun 2012 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
    • 29 Dec 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top